title: Update on oxalate crystal disease.
abstract: Oxalate arthropathy is a rare cause of arthritis characterized by deposition of calcium oxalate crystals within synovial fluid. This condition typically occurs in patients with underlying primary or secondary hyperoxaluria. Primary hyperoxaluria constitutes a group of genetic disorders resulting in endogenous overproduction of oxalate, whereas secondary hyperoxaluria results from gastrointestinal disorders associated with fat malabsorption and increased absorption of dietary oxalate. In both conditions, oxalate crystals can deposit in the kidney leading to renal failure. Since oxalate is primarily renally eliminated, it accumulates throughout the body in renal failure, a state termed oxalosis. Affected organs can include bones, joints, heart, eyes, and skin. Since patients can present with renal failure and oxalosis before the underlying diagnosis of hyperoxaluria has been made, it is important to consider hyperoxaluria in patients who present with unexplained soft tissue crystal deposition. The best treatment of oxalosis is prevention. If patients present with advanced disease, treatment of oxalate arthritis consists of symptom management and control of the underlying disease process.
authors.affiliation: Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
authors.forename: Elizabeth C
authors.initials: EC
authors.lastname: Lorenz
authors.forename: Clement J
authors.initials: CJ
authors.lastname: Michet
authors.forename: Dawn S
authors.initials: DS
authors.lastname: Milliner
authors.forename: John C
authors.initials: JC
authors.lastname: Lieske
mesh_terms: D001168:Arthritis / Q000175:diagnosis / Q000209:etiology* / Q000378:metabolism / Q000628:therapy; D002129:Calcium Oxalate / Q000032:analysis; D006801:Humans; D006959:Hyperoxaluria / Q000150:complications* / Q000628:therapy; D013582:Synovial Fluid / Q000378:metabolism
chemical_list: D002129:Calcium Oxalate